Agree. Most important thing now is management continue to deliver, demonstrate the ramp up/acceleration for Morrilla and keep tick the boxes on both our world class, fully funded projects
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%